KAELIE SALISBURY: Open Payments
NPI 1366012866 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 36 payments from 11 companies in 2025. Trend: 2023 $254 · 2024 $130 · 2025 $797
Food & beverage: $698Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 13 | $266 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $217 |
| Sumitomo Pharma America, Inc. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Sage Therapeutics, LLC | 3 | $56 |
| MILLICENT US INC | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| CooperSurgical, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $15 |
Products named: Veozah, ANNOVERA, GEMTESA, ZURZUVAE, Mirena, Lynkuet, FEMLYV, Qelbree.
Industry payments across AL — which companies pay providers there.
